Identifying Nogo-B Receptor as a Resilience Factor in Preventing Obesity-Associated Type 2 Diabetes

被引:0
|
作者
Mohiuddin, Mohammad Sarif
Hu, Wenquan
Barua, Rashu
Tirumalasetty, Munichandra B.
Choubey, Mayank
Miao, Qing
机构
关键词
D O I
10.2337/db24-343-OR
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
343-OR
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Activation of Nogo-B receptor expression ameliorates type 2 diabetes in mice by improving insulin sensitivity
    Chen, Yi
    Li, Qi
    Duan, Yajun
    Yang, Xiaoxiao
    Chen, Yuanli
    Han, Jihong
    FASEB JOURNAL, 2020, 34
  • [2] The role of macrophage migration inhibitory factor in obesity-associated type 2 diabetes
    Cvjeticanin, T.
    Stosic-Grujicic, S.
    Sandler, S.
    Stojanovic, I.
    DIABETOLOGIA, 2009, 52 : S246 - S246
  • [3] Epigenetic Regulation of Obesity-Associated Type 2 Diabetes
    Ibrahim, Hairul Islam Mohamed
    MEDICINA-LITHUANIA, 2022, 58 (10):
  • [4] THE ROLE OF MACROPHAGE MIGRATION INHIBITORY FACTOR IN OBESITY-ASSOCIATED TYPE 2 DIABETES IN MICE
    Saksida, Tamara
    Stosic-Grujicic, Stanislava
    Stojanovic, Ivana
    ARCHIVES OF BIOLOGICAL SCIENCES, 2013, 65 (02) : 499 - 505
  • [5] Identifying NogoB Receptor As A Resilience Factor In Preventing Diabetes-associated Vasculature Complications Through The Regulation Of Histone Acetylation
    Mohiuddin, Mohammad Sarif
    Hu, Wenquan
    Choubey, Mayank
    Barua, Rashu
    Tirumalasetty, Munichandra Babu
    Wahiduzzaman, Md
    Miao, Qing R.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2024, 44
  • [6] Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
    Haya Al-Sulaiti
    Ilhame Diboun
    Maha V. Agha
    Fatima F. S. Mohamed
    Stephen Atkin
    Alex S. Dömling
    Mohamed A. Elrayess
    Nayef A. Mazloum
    Journal of Translational Medicine, 17
  • [7] LUMINAL COATING OF THE INTESTINE FOR TREATMENT OF OBESITY-ASSOCIATED TYPE 2 DIABETES
    Lo, T.
    Lee, Y.
    Tseng, C. -Y.
    Hu, Y.
    Mantzoros, C.
    Briefs, N.
    Karp, J.
    Tavakkoli, A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A192 - A193
  • [8] Metabolic signature of obesity-associated insulin resistance and type 2 diabetes
    Al-Sulaiti, Haya
    Diboun, Ilhame
    Agha, Maha V.
    Mohamed, Fatima F. S.
    Atkin, Stephen
    Domling, Alex S.
    Elrayess, Mohamed A.
    Mazloum, Nayef A.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
  • [9] Lumican modulates adipocyte function in obesity-associated type 2 diabetes
    Strieder-Barboza
    Flesher, Carmen G.
    Geletka, Lynn
    Eichler, Tad
    Akinleye, Olukemi
    Ky, Alexander P.
    Ehlers, Anne N.
    Lumeng, Carey W.
    O'Rourke, Robert
    ADIPOCYTE, 2022, 11 (01) : 665 - 675
  • [10] Immune Cells Link Obesity-associated Type 2 Diabetes and Periodontitis
    Zhu, M.
    Nikolajczyk, B. S.
    JOURNAL OF DENTAL RESEARCH, 2014, 93 (04) : 346 - 352